One-off factors boost Kyowa Kirin's pharma ops
This article was originally published in Scrip
Executive Summary
Pharmaceutical sales at Kyowa Hakko Kirin (KHK) in Japan jumped by 52% to ¥210.4 billion ($2.12 billion) in the year ended March 31st, boosted by one-off gains.